Adaptive Biotechnologies Corporation Stock
Stocks
ADPT
US00650F1093
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
00:00:00 07/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 27.98 USD | +4.29% |
|
+5.03% | +72.29% |
| Market Cap | 4.53B 4.06B 3.71B 3.39B 6.39B 426B 6.59B 44.75B 17.84B 227B 17B 16.64B 717B | P/E 2026 * |
-51.9x | P/E 2027 * | -162x |
|---|---|---|---|---|---|
| Enterprise Value | 4.24B 3.8B 3.48B 3.17B 5.98B 399B 6.17B 41.91B 16.71B 213B 15.92B 15.58B 672B | EV / Sales 2026 * |
14.5x | EV / Sales 2027 * | 11.7x |
| Free-Float |
97.95% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ADPT | Delayed | |
CBOE
| ADPT | Real-time | |
Boerse Muenchen
| 1HM | Real-time | |
Tradegate
| 1HM | Real-time | |
Deutsche Boerse AG
| 1HM | Delayed | |
Börse Stuttgart
| 1HM | Delayed |
Last Transcript: Adaptive Biotechnologies Corporation
| 1 day | +4.29% | ||
| 1 week | +5.03% | ||
| Current month | +5.03% | ||
| 1 month | +4.01% | ||
| 3 months | +18.56% | ||
| 6 months | +93.90% | ||
| Current year | +72.29% |
| 1 week | 24.8 | 28.27 | |
| 1 month | 23.82 | 29.05 | |
| Current year | 12 | 30.74 | |
| 1 year | 12 | 30.74 | |
| 3 years | 2.28 | 30.74 | |
| 5 years | 2.28 | 37.55 | |
| 10 years | 2.28 | 71.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Chad Robins
CEO | Chief Executive Officer | 51 | 08/09/2009 |
Kyle Piskel
DFI | Director of Finance/CFO | 42 | 08/04/2024 |
Julie Rubinstein
PSD | President | 54 | 01/02/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Chad Robins
CHM | Chairman | 51 | - |
Robert Hershberg
BRD | Director/Board Member | 63 | 01/02/2013 |
Peter Neupert
BRD | Director/Board Member | 70 | 01/12/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/16/26 A | Exercice | Chairperson | 35,643 | 0.0223% | ||
| 10/13/26 A | Exercice | Chairperson | 35,643 | 0.0223% | ||
| 10/8/26 A | Exercice | Chairperson | 35,643 | 0.0223% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +4.29% | +5.03% | +79.82% | +482.92% | 4.34B | ||
| -4.83% | +3.51% | +53.62% | +61.75% | 69.4B | ||
| -1.34% | +2.98% | +24.79% | +100.18% | 57.62B | ||
| +0.02% | +1.07% | +10.63% | +76.66% | 57.24B | ||
| +5.09% | +9.89% | +22.45% | +107.48% | 44.03B | ||
| +2.62% | +1.68% | +28.91% | +37.01% | 43.65B | ||
| +8.24% | +0.51% | +213.26% | +792.66% | 38.08B | ||
| -1.86% | +10.13% | +26.82% | +53.22% | 36.31B | ||
| -2.97% | -9.84% | +88.86% | +76.17% | 32.61B | ||
| -2.18% | +7.06% | +36.06% | -4.95% | 25.47B | ||
| Average | +0.71% | +4.30% | +58.52% | +178.31% | 40.88B | |
| Weighted average by Cap. | +0.10% | +4.27% | +52.03% | +140.34% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 293M 263M 240M 219M 413M 27.57B 426M 2.9B 1.16B 14.71B 1.1B 1.08B 46.43B | 360M 323M 295M 269M 508M 33.85B 524M 3.56B 1.42B 18.06B 1.35B 1.32B 57.03B |
| Net income | -85.62M -76.79M -70.18M -64.06M -121M -8.05B -125M -846M -337M -4.29B -321M -314M -13.56B | -27.23M -24.42M -22.32M -20.38M -38.39M -2.56B -39.6M -269M -107M -1.37B -102M -100M -4.31B |
| Net Debt | -287M -258M -235M -215M -405M -27B -418M -2.84B -1.13B -14.41B -1.08B -1.05B -45.48B | -331M -297M -271M -248M -466M -31.1B -481M -3.27B -1.3B -16.59B -1.24B -1.22B -52.38B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/11/26 | $27.98 | +4.29% | 3,333,525 |
| 05/11/26 | $26.83 | +0.45% | 4,045,321 |
| 04/11/26 | $26.71 | +3.53% | 2,328,997 |
| 03/11/26 | $25.80 | +2.95% | 1,512,841 |
| 02/11/26 | $25.06 | -5.93% | 2,337,378 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ADPT Stock
Select your edition
All financial news and data tailored to specific country editions

















